MOUNTAIN VIEW, Calif., Jan 21, 2009 - Omnicell, Inc. (Nasdaq: OMCL), a leading provider of system solutions to acute healthcare facilities, will hold a conference call Thursday, January 29 to discuss the Company's fourth quarter 2008 financial results. What: Omnicell fourth quarter 2008 earnings

ORLANDO, Fla., Dec 08, 2008 /PRNewswire-FirstCall via COMTEX News Network/ - ASHP Midyear Clinical Meeting and Exhibition - Omnicell, Inc. (Nasdaq: OMCL), a leading provider of system solutions to acute healthcare facilities, today announced improved anesthesia medication management features in

MOUNTAIN VIEW, Calif., Nov 26, 2008 /PRNewswire-FirstCall via COMTEX News Network/ - Omnicell, Inc., (Nasdaq: OMCL) a leading provider of system solutions to acute healthcare facilities, today announced that it has attained Gold Certified Partner status in the Microsoft Certified Partner (MCP)

Omnicell Announces Third Quarter 2008 Results MOUNTAIN VIEW, Calif. – October 23, 2008 – Omnicell, Inc. (NASDAQ: OMCL), a leading provider of system solutions to acute healthcare facilities, today announced results for its quarter ended September 30, 2008. GAAP results: Revenues for the

Omnicell Reports Fourth Quarter and Full-Year 2007 Results MOUNTAIN VIEW, Calif. – January 31, 2008 – Omnicell, Inc. (NASDAQ: OMCL), a leading provider of system solutions to acute healthcare facilities, today announced results for its fourth quarter ended December 31, 2007. GAAP

The first sentence of the second paragraph of the release dated Feb. 15, 2023, has been corrected to replace the dial-in numbers for the earnings call on Tuesday, February 28, 2023. The updated release reads: OMNICELL TO RELEASE FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS ON FEBRUARY 28, 2023 Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the fourth quarter and full year 2022, after market on Tuesday, February 28, 2023. The Company will host a conference call and webcast to discuss its financial results at 4:30 p.m. ET that same day. All interested parties are invited to listen to the live call and presentation by dialing (888) 550-5424 in the U.S. or (646) 960-0819 in international locations. A link to the live and archived webcast will also be available on the Investor Relations section of Omnicell’s website at

2022 Total Bookings of $1.054 billion Full Year 2022 GAAP Revenues of $1.296 and non-GAAP Revenues of $1.297 billion Ended Year with Over 150 Long-Term, Sole-Source Agreements with the Top 300 U.S. Health Systems Year End 2022 Backlog of $1.215 billion Chief Financial Officer to Step Down effective July 1, 2023 Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for fiscal year and fourth quarter ended December 31, 2022. “Omnicell delivered results generally exceeding our revised outlook for the fourth quarter and full year 2022 in the face of continued headwinds and macroeconomic uncertainty,” said Randall Lipps, Founder, Chairman, President and Chief Executive Officer of Omnicell. “Omnicell has strong customer relationships, unique expertise within medication management, and compelling Advanced Services

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the first quarter 2023 after market close on Tuesday, May 2, 2023. The Company will host a conference call and webcast to discuss its financial results at 4:30 p.m. ET that same day. All interested parties are invited to listen to the live call and presentation by dialing (888) 550-5424 in the U.S. or (646) 960-0819 in international locations. A link to the live and archived webcast will also be available on the Investor Relations section of Omnicell’s website at https://ir.omnicell.com/events-and-presentations/ . About Omnicell Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Through the vision of the autonomous pharmacy, a combination of automation, intelligence, and technology-enabled services, powered by a cloud

Total GAAP revenues of $291 million GAAP net loss per diluted share of $0.33 Non-GAAP net income per diluted share of $0.39 Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced results for its first quarter ended March 31, 2023. “We are pleased with the financial performance this quarter,” said Randall Lipps, chairman, president, chief executive officer, and founder of Omnicell. “As our customers continue to navigate post-pandemic challenges, we believe delivering solutions that are designed to support optimized clinical and business outcomes are more important than ever. We remain confident that we are well-positioned to continue executing on our strategy and to drive long-term value for our stockholders and our healthcare partners and their patients.” Financial Results Total GAAP revenues for the first quarter of 2023 were $291 million, down $28 million, or 9%, from

Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, announced that it will present at the BofA Securities 2023 Healthcare Conference on Thursday, May 11, 2023 at 8:00 a.m. PT. Live and archived webcasts of the presentation will be available through the Omnicell website at: https://ir.omnicell.com/events-and-presentations/ About Omnicell Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model in an effort to optimize financial and clinical outcomes across all settings of care. Through a comprehensive portfolio of automation and advanced services, Omnicell is uniquely positioned to address evolving healthcare challenges, connect settings of care, and streamline the medication management process. Healthcare facilities worldwide partner with Omnicell to help increase operational efficiency, reduce medication errors, improve patient safety, and enhance patient engagement and adherence,

Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced changes to its leadership structure designed to create a more streamlined organization with a continued focus on operational excellence, driving continuous improvements in customer experience and the delivery of Omnicell’s long-term commitments. “Omnicell continues to evolve in an effort to meet the ever-changing needs of the industry as we work to execute our strategy to transform the pharmacy care delivery model,” said Randall Lipps, chairman, president, chief executive officer, and founder of Omnicell. “In recent years, we have transitioned our business to increase our focus on ‘SaaS’ and tech-enabled services, including launching our Advanced Services portfolio, Cloud Platform, and Customer Success Organizations, as we seek to better meet the needs of our customers. With these efforts complete, we think now is the right time to reorganize our

Omnicell, Inc. , ( NASDAQ : OMCL), today announced it is realigning its organization to continue its growth strategy of offering differentiated products, expanding into new markets and increasing its presence through acquisitions. Over the past year, Omnicell has expanded its solutions and market

Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced that Peter Kuipers has joined the company as Executive Vice President, Chief Financial Officer. Mr. Kuipers brings 20 years of financial and business strategy

Omnicell, Inc. (NASDAQ:OMCL) today announced that LCMC Health has selected Omnicell medication dispensing technology for their newest state-of-the-art facility, the University Medical Center New Orleans (UMC New Orleans), which hopes to better serve the needs of people with complex medical problems

Omnicell, Inc. (Nasdaq: OMCL), a leading provider of system solutions to acute healthcare facilities, will hold a conference call Monday, April 26 to discuss the Company's First Quarter 2010 financial results. Omnicell First Quarter 2010 earnings conference call What: and webcast When: April 26,

MOUNTAIN VIEW, Calif., Dec 17, 2009 /PRNewswire-FirstCall via COMTEX News Network/ - Omnicell, Inc ., (Nasdaq: OMCL) a leading provider of medication system solutions to acute healthcare facilities, today announced that CoxHealth, a Top 100 Integrated Health Care Network in Springfield, Missouri,